SHL Telemedicine
- Company typePublic
- Founded1987
- HeadquartersTel Aviv, Israel
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingServices
SHL Telemedicine firmographics
Firmographics- Name
- SHL Telemedicine
- Legal name
- SHL Telemedicine Ltd.
- Website
- https://shl-telemedicine.com
- Company type
- Public
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
SHL Telemedicine industry classification
Industry- Product category
- Remote Cardiac and Chronic Disease Telemedicine Services
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Services for the Elderly and Persons with Disabilities (624120)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000)
- akta.pro primary industry
- Cardiology Telemedicine Platforms (HLALAGAB)
- akta.pro secondary industries
- Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC)
Keywords
Where SHL Telemedicine is headquartered
LocationHeadquarters
- HQ city
- Tel Aviv
- HQ country
- Israel
- HQ region
- Middle East
Offices3 records
Markets served
SHL Telemedicine business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Telemedicine Services Revenue: SHL generates revenue primarily through telemedicine monitoring services provided to health insurers, payers, hospitals, and directly to patients. Services include 24/7 cardiac monitoring, chronic disease management for CHF and COPD patients, and acute cardiac care programs. Revenue from 2025 was USD 58,694 thousand.
- Medical Device Sales: Sale of FDA-cleared medical devices including SmartHeart Pro, CardioSen'C, Cardio'B, TelePress, TeleWeight, TeleBreather, and TelePulse Oximeter. These devices are sold directly to consumers and through healthcare provider partnerships.
- Technology Licensing: Licensing of SmartHeart technology to healthcare partners including Mayo Clinic, CVS Health, VNA Care, ChristianaCare, and Post-Acute Medical for use across different platforms and clinical settings.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | B2B Telemedicine Services |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels5 records
SHL Telemedicine product offering
Product offeringCore offering
SHL Telemedicine provides remote cardiac and chronic disease monitoring services via its cloud-based telemedicine platform and FDA-cleared 12-lead ECG devices (SmartHeart, CardioSen'C, Cardio'B). The company operates 24/7 monitoring centers staffed by medical professionals that receive, interpret, and act on ECG and vital signs transmissions from patients at home. Its offerings are sold both as enterprise contracts to health insurers, payers, and hospitals and as OTC consumer devices via retail channels.
Product overview
SHL Telemedicine offers a comprehensive telemedicine platform combining FDA-cleared mobile 12-lead ECG devices with 24/7 monitoring services. The core portfolio includes SmartHeart®/SmartHeartPro© (FDA-cleared hospital-grade 12-lead ECG with cloud-based data and 15-minute turnaround), CardioSen'C™ (cellular-digital ECG transmitter), Cardio'B™ (ergonomic portable ECG), and CardioBeeper 12/12™ (telephone-line ECG). Supporting monitoring devices include TelePress™ (blood pressure), TeleWeight™ (weight), TeleBreather™ (lung function), and TelePulse Oximeter (oxygen saturation), all connected via the CCM™ Central Communication Module. The platform is complemented by 24/7 telemedicine centers in Israel and Germany providing professional medical staff monitoring and Personal Health Records. The system uses AI and big data to detect anomalies and trigger alerts when patient vital signs deviate from baselines.
Differentiator
Problem solved
Functional benefit
Brands
- SmartHeartPro: FDA cleared hospital-grade 12-lead ECG platform for professional use
- SmartHeart
- TelePress
- CardioSen'C
- Cardio'B
- CCM
- TeleWeight
- TeleBreather
- TelePulse Oximeter
Products and services
- SmartHeart / SmartHeartPro FDA-cleared mobile hospital-grade 12-lead ECG device for personal use that enables detection of heart attacks without assistance from a medical professional. Data is stored in the cloud and is HIPAA compliant, with 24/7 telemedicine center support and 15-minute ECG report turnaround. Sold to health insurers, hospitals, and directly to consumers via retail channels.
- CardioSen'C First personal cellular-digital 12-lead ECG transmitter that sends a patient's complete 12-lead ECG and rhythm read-out strip in real time to a medical monitoring center for evaluation of arrhythmia, ischemia, and myocardial infarction.
- Cardio'B Lightest portable 12-lead ECG transmitter device of its kind, designed for ECG transmissions from home, office, and on the go. Features ergonomic design, acoustic transmission via any phone connection, and user-friendly operation with less than a minute transmission time.
- CardioBeeper 12/12 FDA-cleared hand-held ECG transmitter for personal use that transmits a full 12-lead ECG via standard telephone line in seconds, enabling real-time diagnosis of arrhythmia, ischemia, and myocardial infarction.
- CCM (Central Communication Module) Innovative telecommunication device that transmits medical data from SHL monitoring devices to telemedicine centers. Supports Internet, cellular, or landline transmission with compact plug-and-play design, no control buttons, automatic data encryption, and remote software updates.
- TelePress Remote blood pressure monitoring device for personal use with one-touch automatic self-pressurization. Measures heart rate and systolic and diastolic values, with real-time response to abnormal measurements and early identification of unfavorable trends.
- TeleWeight Trans-telephonic weight monitoring device that automatically measures and transmits weight data to the medical monitoring center, designed to detect fluid accumulation in the body and trigger alerts for congestive heart failure patients.
- TeleBreather Remote handheld device for testing lung function by measuring air volumes expelled during exhalation and exhalation speed, intended for COPD and chronic lung condition patients.
- TelePulse Oximeter Handheld diagnostic device for measuring blood oxygen saturation (SpO2) and pulse rate at home, intended for chronic lung-heart disease patients including COPD.
- 24/7 Telemedicine Monitoring Centers 24/7 telemedicine centers staffed by professional medical teams that provide immediate feedback, reassurance, emergency facilitation, and hospital coordination for patients using SHL devices. Located in Israel and Germany and processing approximately 3 million medical interactions per year.
- Personal Health Records Online secured personal health records containing demographic data, medical history, ECG results, blood pressure readings, weight measurements, medication data, and hospitalization records, accessible to patients and physicians.
Quantifiable outcome
- Extended clinical study by Israeli Heart Society concludes that SHL service significantly increases probability of users surviving the first year after a heart attack
- +3 more outcomes
Companies that use SHL Telemedicine
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles3 records
SHL Telemedicine technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature8 records
SHL Telemedicine partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- Israeli Ministry of DefensecoreSHL subsidiary Mediton awarded continued provision of services to Israeli Ministry of Defense, representing ongoing government partnership for healthcare services.
- BNK (German Society of Cardiologists in Private Practice)coreCollaboration agreement across Germany for use of SHL Telemedicine services, integrating SHL technology into cardiologists' private practice workflows.
- Post-Acute MedicalcoreCollaboration using SmartHeart 12 lead ECG Technology for post-acute care settings, expanding access to cardiac monitoring in rehabilitation and post-hospital recovery environments.
- ChristianaCarecoreAgreement for use of SmartHeart full 12 lead ECG technology. ChristianaCare is among the largest regional heart centers on the East Coast, enabling broad patient access to cardiac monitoring services.
- AOK Rheinland-Pfalz/SaarlandcoreLarge contract for providing Telehealth Services to Geriatric Patients, expanding SHL's presence in the German geriatric care market.
- CVS Health / CVS Pharmacy Inc.coreAgreement for use of SmartHeart full 12 lead ECG technology. CVS Health later expanded the use of SmartHeart technology, demonstrating successful partnership and product validation in retail healthcare settings.
- Mediton GroupcoreSHL closed acquisition of 70% of Mediton Group companies (leading B2B healthcare services provider in Israel) in September 2021. In March 2025, SHL acquired the remaining stake, achieving 100% ownership. Mediton provides additional B2B healthcare services.
- AOK BayerncoreMulti-year large Chronic Disease Telehealth contract awarded following a tender to provide service to congestive heart failure (CHF) patients. Tens of thousands of SHL home systems installed across Germany.
- BARMERcoreBARMER health insurance company announced that all of its insureds in Germany will have access to the video consultation doctors' virtual visit service provided by SHL Telemedicine.
- VNA CarecoreCollaboration for use of SmartHeart 12 Lead ECG technology in VNA Care's home health care services. Helps individuals return home from hospital sooner and manage newly diagnosed illnesses.
- Jumedi GmbHminorSHL German subsidiary closed acquisition of 100% of Jumedi GmbH, a developer of Digital Health technologies, strengthening leadership of German operation and adding digital health development capabilities.
- Mayo CliniccoreStrategic collaboration for use of SmartHeart technology across different platforms. SmartHeart is already being used at Mayo Clinic and will now be implemented for broader use. This partnership validates SHL's technology through one of the world's leading healthcare systems.
Scale indicators9 records
Recent moves10 records
Expansion highlights6 records
SHL Telemedicine competitors and assessment
Company assessmentEmerging players
- Heartbeat Health: Heartbeat Health is a US virtual cardiology platform offering remote cardiac care, ECG review, and chronic disease management programs. Comparable to SHL's payor- and provider-channel telehealth cardiology services, though more US-centric and earlier stage.
- Biotricity: Biotricity is a smaller US-based remote cardiac monitoring company offering devices and RPM services for arrhythmia and chronic disease. Comparable to SHL in providing connected cardiac RPM with subscription analytics, but at a meaningfully smaller scale and narrower commercial footprint.
- Eko Health: Eko Health produces FDA-cleared digital stethoscopes and AI-powered cardiac decision support, including the CORE 500 digital stethoscope with embedded ECG. Overlaps with SHL in AI-driven cardiac auscultation and rhythm analysis, but Eko focuses on clinician-side tools rather than direct-to-patient 12-lead monitoring.
- Withings: Withings produces consumer health devices including the ScanWatch with embedded single-lead ECG and SpO2. Comparable to SHL in bringing clinical-grade vitals/ECG to the consumer home, but distributes through a consumer-electonics retail channel rather than payor/clinical contracting.
Broad incumbents
- Boston Scientific (Preventice Solutions): Boston Scientific acquired Preventice Solutions, a US provider of ambulatory ECG monitors and connected cardiac diagnostics. Comparable to SHL in providing connected cardiac monitoring with central interpretation, but operates within Boston Scientific's much broader interventional and structural heart franchise.
- Medtronic (Cardiac Diagnostics): Medtronic's Cardiac Diagnostics business — including the Reveal LINQ insertable cardiac monitor and connected diagnostics services — represents a large incumbent in remote cardiac monitoring with implantable and external devices. Comparable to SHL for ECG-based remote diagnostics, though Medtronic spans implantable CRM and broader hospital capital equipment.
- Philips (BioTelemetry): Royal Philips acquired BioTelemetry to enter ambulatory cardiac monitoring (mobile cardiac telemetry, event monitoring, Holter). As a large medical-device incumbent, Philips competes with SHL in cardiac remote monitoring via established hospital and payor channels, but offers a much broader clinical product portfolio beyond SHL's specialty focus.
- GE HealthCare (Marquette ECG): GE HealthCare's cardiology portfolio includes diagnostic ECG, cardiac ultrasound, and patient monitoring solutions widely deployed in hospitals. Comparable to SHL as a provider of clinical-grade ECG and cardiac monitoring infrastructure, though GE operates primarily in hospital capital equipment rather than payor-funded home telemedicine.
Direct peers
- iRhythm Technologies: iRhythm Technologies is a US-based cardiac ambulatory monitoring company known for the Zio long-term ECG patch and AI-based arrhythmia detection. Comparable to SHL in serving cardiology patients with continuous remote ECG monitoring and central interpretation services, though SHL emphasizes 12-lead mobile ECG while iRhythm emphasizes patch-based extended wear.
- AliveCor: AliveCor manufactures KardiaMobile, an FDA-cleared personal ECG device including the 6-lead KardiaMobile 6L, and is the closest direct competitor to SHL's SmartHeart in the consumer/clinical personal 12-6 lead ECG category. Both companies target cardiology-focused remote monitoring but AliveCor leans consumer/OTC while SHL anchors payor and clinical provider channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
SHL Telemedicine social profiles
Digital presenceSHL Telemedicine compliance and trust
Trust signalCompliance4 records
SHL Telemedicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
SHL Telemedicine leadership team
Management profileNumber of profiles
Profiles7 records
SHL Telemedicine subsidiaries and ownership
Company hierarchySubsidiaries3 records
SHL Telemedicine funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SHL Telemedicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SHL Telemedicine
What does SHL Telemedicine do?
SHL Telemedicine provides remote cardiac and chronic disease monitoring services via its cloud-based telemedicine platform and FDA-cleared 12-lead ECG devices (SmartHeart, CardioSen'C, Cardio'B). The company operates 24/7 monitoring centers staffed by medical professionals that receive, interpret, and act on ECG and vital signs transmissions from patients at home. Its offerings are sold both as enterprise contracts to health insurers, payers, and hospitals and as OTC consumer devices via retail channels.
Is SHL Telemedicine a public or private company?
SHL Telemedicine is a public company. It is classified as public and is currently operating.
When was SHL Telemedicine founded?
SHL Telemedicine was founded in 1987. It employs 501 to 1,000 people.
Where is SHL Telemedicine based?
SHL Telemedicine is headquartered in Tel Aviv, Israel, in the Middle East region.
How does SHL Telemedicine make money?
Three revenue lines are on record. Telemedicine Services Revenue is the primary driver. The others are medical Device Sales and technology Licensing.
Who are SHL Telemedicine's main competitors?
Emerging players on record are Heartbeat Health, Biotricity, Eko Health and Withings. Broad incumbents are Boston Scientific (Preventice Solutions), Medtronic (Cardiac Diagnostics), Philips (BioTelemetry) and GE HealthCare (Marquette ECG). Direct peers are iRhythm Technologies and AliveCor.
Does SHL Telemedicine have an API?
No public API is recorded for SHL Telemedicine.
What industry is SHL Telemedicine in?
SHL Telemedicine's product category is Remote Cardiac and Chronic Disease Telemedicine Services. Its primary akta.pro industry code is HLALAGAB, Cardiology Telemedicine Platforms, with a secondary code of HLALADAD, Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN). Its NAICS code is 334510 and its SIC code is 3845.